RNS Number : 3845N
Ilika plc
22 November 2024
 

Ilika plc

("Ilika", the "Group", or the "Company")

 

AIM Rule 17 Schedule 2(g) Update

 

Ilika (AIM: IKA), an independent global expert in solid-state battery technology, announces the following update in relation to directors' disclosure for Keith Jackson, Non-Executive Chairman of the Company, pursuant AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

Libertine plc, a company of which Keith Jackson was a Non-Executive Chairman until 24 August 2024, was placed into administration on 27 August 2024.

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Jason Stewart, Chief Financial Officer

Via FTI Consulting







Panmure Liberum Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber, John More


Nikhil Varghese, Joshua Borlant






Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Matthew Armitt, Mark Whitmore, Detlir Elezi,


Angus Murphy






FTI Consulting (Comms Advisors)

ilika@fticonsulting.com

Ben Brewerton


Elizabeth Adams


Dwight Burden


 

About Ilika plc - https://www.ilika.com

Ilika specialises in the developing and commercialisation of solid-state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.

 

The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist Internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUUASRSAUAUAA